About Biogen
Biogen is a biotechnology company founded in 1978 and headquartered in Cambridge, Massachusetts, where it also conducts research operations. Using an understanding of human biology and different modalities, it develops medicines and therapies to advance first-in-class treatments aimed at improving patient outcomes. Simple enough.
The company employs approximately 7,000 people worldwide and operates internationally from its headquarters in Baar, Switzerland, with manufacturing facilities in North Carolina and Solothurn, Switzerland. Biogen provides therapies through direct affiliates in 30 countries and distribution partners in more than 50 additional countries. That footprint is broad.
Need to reach the Biogen team directly? Find verified work emails for every employee with Snov.io
Insights
Updated 31 Aug 2026Biogen is being positioned by market commentators as a healthcare name to own outside the AI and data-center capital spending theme. In a recent CNBC Halftime Report appearance, Josh Brown singled out Biogen as one of his “Best Stocks in the Market,” alongside Incyte. That points to relative investor interest in defensive healthcare exposure.
The available sources do not provide operating results or product updates. Still, they do suggest continued institutional engagement. Wellington Management increased its Biogen stake by 5.3% in the second quarter, and Rakuten Investment Management initiated a new position, both of which point to ongoing portfolio interest in the stock.
Taken together, the recent commentary and holdings activity imply that Biogen is drawing attention as a non-AI healthcare alternative rather than on a near-term earnings or consumer-demand story. No hiring, funding, or earnings details are mentioned in the sources, so sentiment is the clearest signal in this set.
Frequently asked questions
Biogen is headquartered in Cambridge, Massachusetts, United States.
Biogen has 5001-10000 employees according to its company profile.
Biogen operates in the Biotechnology sector. Public valuation figures are not always disclosed for private companies.